Explore the complete record of transactions filed by Shetzline Michael, CMO, SVP & Responsable du Développement Médical. Officer active across 1 companies, notably Ironwood Pharmaceuticals INC. Cumulatively, 9 filings have been published. Total volume traded: €372k. The latest transaction was filed on 23 May 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Michael Shetzline is the CMO, Senior Vice President, and Head of Drug Development at Ironwood Pharmaceuticals Inc. He oversees drug development initiatives, focusing on innovation and efficiency. His expertise in the pharmaceutical field is crucial for the success of the company's research and development projects.